Health
Health News
BenevolentAI Appoints New Chief Technology Officer. LONDON, BENEVOLENTAI
LONDON-(BUSINESS WIRE) BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug...
Read moreBenevolentAI: Publication of 2023 Annual Report and 2024 AGM Notice. LONDON, BENEVOLENTAI
LONDON-(BUSINESS WIRE) Regulatory News: BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate...
Read moreDr. Reddy’s Laboratories launches Versavo® (bevacizumab) in the UK. HYDERABAD, India, DR.-REDDY’S-LABORATORIES
HYDERABAD, India-(BUSINESS WIRE) Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr....
Read moreWithin3 and Array Announce Partnership to Set New Standards in Life Science Stakeholder Engagement. LAKEWOOD, Ohio & DENVER, OH-WITHIN3/ARRAY
LAKEWOOD, Ohio & DENVER-(BUSINESS WIRE) In a significant move to transform life science stakeholder engagement, Within3 and Array have announced...
Read morePrecision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy. DURHAM, N.C., NC-PRECISION-BIOSCIENCES
DURHAM, N.C.-(BUSINESS WIRE) Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to...
Read moreForge Biologics’ Novel AAV Gene Therapy FBX-101 for Patients with Krabbe Disease is Granted UK’s Innovation Passport Designation. COLUMBUS, Ohio, OH-FORGE-BIOLOGICS
COLUMBUS, Ohio-(BUSINESS WIRE) Forge Biologics, a member of Ajinomoto Bio-Pharma Services and a leading manufacturer of genetic medicines, today announced...
Read moreGRAIL Announces Novel Risk Classification Test to Be Used in Lung Cancer Study. MENLO PARK, Calif. & CAMBRIDGE, England, CA-GRAIL-LLC
MENLO PARK, Calif. & CAMBRIDGE, England-(BUSINESS WIRE) GRAIL, LLC, a healthcare company whose mission is to detect cancer early when...
Read moreNeupulse Secures Funding to Advance World’s First Wearable Device to Tackle Tourettes Syndrome. NOTTINGHAM, England, NEUPULSE
NOTTINGHAM, England-(BUSINESS WIRE) Neupulse has secured funding to advance the world’s first wearable device aimed at tackling Tourettes Syndrome (TS)...
Read moreKalVista Pharmaceuticals Presents Real-World Data on Burden of Treatment and HAE Attack Journey at the 2024 HAEi Regional Conference Americas. CAMBRIDGE, Mass. & SALISBURY, England, MA-KALVISTA
CAMBRIDGE, Mass. & SALISBURY, England-(BUSINESS WIRE) KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery,...
Read moreArrayjet’s ArrayPlex Platform Selected by Immunome for Use in Its Discovery of Targeted Cancer Therapies. EDINBURGH, Scotland, ARRAYJET
EDINBURGH, Scotland-(BUSINESS WIRE) Arrayjet, a leading provider of inkjet liquid-handling solutions, today announced that its ArrayPlex™ discovery platform has been...
Read more